Ex vivo assessment of cellular mass response for personalized therapy selection of hyperthermic intraperitoneal chemotherapy (HIPEC) agents.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399737664
